Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II (SPARTACUSII)
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II: A Phase II Randomized Controlled Trial
Sponsor: Credit Valley Hospital
This NA trial investigates Endometrial Cancer and is currently ongoing. Credit Valley Hospital leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Nov 2021 — Nov 2023 [monthly]
Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jun 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Credit Valley Hospital
- London Regional Cancer Program, Canada
- Princess Margaret Hospital, Canada
- Royal Victoria Hospital, Canada
- Sunnybrook Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .